Is endothelial progenitor cell senescence a therapeutic target in hypertension?

Journal of Hypertension

Volumn 28, Issue 5, 2010, Pages 887-888

  Hadoke, Patrick W F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOSARTAN; RUTAECARPINE;

CELL AGING; CELL LINEAGE; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; NONHUMAN; NOTE; PHAGOCYTOSIS; PRIORITY JOURNAL; STEM CELL;

EID: 77951274336     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328336ede6     Document Type: Note

References (6)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science 1997; 275:964-967. (Pubitemid 27087709)
2. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353:999-1007. (Pubitemid 41262334)
3. van Zonneveld AJ, Rabelink TJ. Endothelial progenitor cells: biology and therapeutic potential in hypertension. Curr Opin Nephrol Hypertens 2006; 15:167-172. (Pubitemid 43755822)
4. Zhou Z, Peng J, Wang C-J, Li D, Li T-T, Hu C-P, et al. Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. J Hypertens 2010; 28:931-939.
5. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348:293-600. (Pubitemid 36204953)
6. Yoder MC, Mead LE, Prater D, Krier DR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and haematopoietic stem/progenitor cell principals. Blood 2007; 109:1801-1809. (Pubitemid 46348173)